Review Articles Concerning Pulmonary Vascular Disease

Oxygen Targets in Neonatal Pulmonary Hypertension: Individualized, “Precision-Medicine” Approach

Satyan Lakshminrusimha, Steven H. AbmanUniversity of California, Davis Children’s Hospital. University of Colorado Anschutz Medical Campus.United States Clinics in PerinatologyClin Perinatol 2024; 51: 77-94DOI: 10.1016/j.clp.2023.12.003 AbstractOxygen is a specific pulmonary vasodilator. Hypoxemia causes pulmonary vasoconstriction, and normoxia leads to pulmonary vasodilation. However, hyperoxia does not enhance pulmonary vasodilation but causes oxidative stress. There are no clinical […]

Oxygen Targets in Neonatal Pulmonary Hypertension: Individualized, “Precision-Medicine” Approach Read More »

Comorbidities and Late Outcomes in Neonatal Pulmonary Hypertension

Emily S. Stieren, Deepika Sankaran, Satyan Lakshminrusimha, Catherine A. RottkampUniversity of California, Davis.United States Clinics in PerinatologyClin Perinatol 2024; 51: 271-289DOI: 10.1016/j.clp.2023.10.002 AbstractLong-term outcomes of persistent pulmonary hypertension of newborn (PPHN) depend on disease severity, duration of ventilation, and associated anomalies. Congenital diaphragmatic hernia survivors may have respiratory morbidities and developmental delay. The presence of PPHN

Comorbidities and Late Outcomes in Neonatal Pulmonary Hypertension Read More »

Randomized Controlled Trials of Pulmonary Vasodilator Therapy Adjunctive to Inhaled Nitric Oxide for Persistent Pulmonary Hypertension of the Newborn: A Systematic Review

Kristen Coletti, K. Taylor Wild, Elizabeth E. Foglia, Suzan Cochius-den Otter, Haresh KirpalaniChildren’s Hospital of Philadelphia and University of Pennsylvania. Erasmus MC University Medical Center.United States and Netherlands Clinics in PerinatologyClin Perinatol 2024; 51: 253-269DOI: 10.1016/j.clp.2023.11.009 AbstractInhaled nitric oxide (iNO) is a pulmonary vasodilator considered standard of care to treat persistent pulmonary hypertension of the newborn.

Randomized Controlled Trials of Pulmonary Vasodilator Therapy Adjunctive to Inhaled Nitric Oxide for Persistent Pulmonary Hypertension of the Newborn: A Systematic Review Read More »

Etiology, Diagnosis and Management of Persistent Pulmonary Hypertension of the Newborn in Resource-limited Settings

Prathik Bandiya, Rajeshwari Madappa, Ajay Raghav JoshiSouth Hospital Complex and Dharmaram College Post. SIGMA Hospital. India Clinics in PerinatologyClin Perinatol 2024; 51: 237-252DOI: 10.1016/j.clp.2023.11.002 AbstractPersistent Pulmonary Hypertension of the Newborn (PPHN) is more common in low and middle income countries (LMICs) due to high incidence of sepsis, perinatal asphyxia and meconium aspiration syndrome. Presence of hypoxic

Etiology, Diagnosis and Management of Persistent Pulmonary Hypertension of the Newborn in Resource-limited Settings Read More »

Pulmonary Hypertension in Developmental Lung Diseases

Olivier Danhaive, Csaba Galambos, Satyan Lakshminrusimha, Steven H. AbmanSaint-Luc University Hospital and University of California San Francisco. University of Colorado Anschutz School of Medicine. University of California, UC Davis Children’s Hospital.Belgium and United States Clinics in PerinatologyClin Perinatol 2024; 51: 217-235DOI: 10.1016/j.clp.2023.12.001 AbstractDiverse genetic developmental lung diseases can present in the neonatal period with hypoxemic respiratory

Pulmonary Hypertension in Developmental Lung Diseases Read More »

Pathogenesis and Physiologic Mechanisms of Neonatal Pulmonary Hypertension: Preclinical Studies

Karen C. Young, Augusto F. Schmidt, April W. Tan, Lourenco Sbragia, Ahmed Elsaie, Binoy ShivannaUniversity of Miami Miller School of Medicine. Ribeirao Preto Medical School. Ascension Via Christi St. Joseph Hospital and Cairo University. Baylor College of Medicine.United States, Brazil and Egypt Clinics in PerinatologyClin Perinatol 2024; 51: 21-43DOI: 10.1016/j.clp.2023.11.004 AbstractNeonatal pulmonary hypertension (PH) is a

Pathogenesis and Physiologic Mechanisms of Neonatal Pulmonary Hypertension: Preclinical Studies Read More »

Pulmonary Hypertension in Established Bronchopulmonary Dysplasia: Physiologic Approaches to Clinical Care

Steven H. Abman, Satyan LakshminrusimhaUniversity of Colorado Anschutz Medical Campus. University of California, Davis Children’s Hospital.United States Clinics in PerinatologyClin Perinatol 2024; 51: 195-216DOI: 10.1016/j.clp.2023.12.002 AbstractPreterm infants with bronchopulmonary dysplasia (BPD) are prone to develop pulmonary hypertension (PH). Strong laboratory and clinical data suggest that antenatal factors, such as preeclampsia, chorioamnionitis, oligohydramnios, and placental dysfunction leading

Pulmonary Hypertension in Established Bronchopulmonary Dysplasia: Physiologic Approaches to Clinical Care Read More »

Early Pulmonary Hypertension in Preterm Infants

Srinivasan Mani, Hussnain Mirza, James Ziegler, Praveen ChandrasekharanUniversity of Toledo and ProMedica Russell J. Ebeid Children’s Hospital. Advent Health for Children and University of Central Florida College of Medicine. Hasbro Children’s Hospital and Brown University. State University of New York at Buffalo and Oishei Children’s Hospital.United States Clinics in PerinatologyClin Perinatol 2024; 51: 171-193DOI: 10.1016/j.clp.2023.11.005 AbstractPulmonary

Early Pulmonary Hypertension in Preterm Infants Read More »

Congenital Diaphragmatic Hernia: Pulmonary Hypertension and Pulmonary Vascular Disease

Shiran S. Moore, Roberta L. Keller, Gabriel AltitDana Dwek Children’s Hospital and Tel Aviv Sourasky Medical Center. UCSF Benioff Children’s Hospital and University of California San Francisco. McGill University Health Centre and Montreal Children’s Hospital.Israel, United States and Canada Clinics in PerinatologyClin Perinatol 2024; 51: 151-170DOI: 10.1016/j.clp.2023.10.001 AbstractThis review provides a comprehensive summary of the current

Congenital Diaphragmatic Hernia: Pulmonary Hypertension and Pulmonary Vascular Disease Read More »

Asphyxia, Therapeutic Hypothermia, and Pulmonary Hypertension

Regan Geisinger, Danielle R. Rios, Patrick J. McNamara, Philip T. LevyUniversity of Iowa. Boston Children’s Hospital and Harvard Medical School.United States Clinics in PerinatologyClin Perinatol 2024; 51: 127-149DOI: 10.1016/j.clp.2023.11.007 AbstractNeonates with a perinatal hypoxic insult and subsequent neonatal encephalopathy are at risk of acute pulmonary hypertension (aPH) in the transitional period. The phenotypic contributors to aPH

Asphyxia, Therapeutic Hypothermia, and Pulmonary Hypertension Read More »

Scroll to Top